New research finds ibuprofen may lower risk of Parkinson’s disease
ST. PAUL, Minn. Ibuprofen may soon join aspirin as a daily analgesic prophylactic.
According to new research released Wednesday, supplementation with ibuprofen may reduce the risk of developing Parkinson’s disease.
The research involved 136,474 people who did not have Parkinson’s disease at the beginning of the research. Participants were asked about their use of non-steroid anti-inflammatory drugs, including aspirin, ibuprofen and acetaminophen. After six years, 293 participants had developed Parkinson’s disease.
The study found regular users of ibuprofen were 40% less likely to develop Parkinson’s disease than people who didn’t take ibuprofen. Also, people who took higher amounts of ibuprofen were less likely to develop Parkinson’s disease than people who took smaller amounts of the drug. The results were the same regardless of age, smoking and caffeine intake, researchers noted.
“Ibuprofen was the only NSAID linked to a lower risk of Parkinson’s,” stated Xiang Gao, of the Harvard School of Public Health in Boston. “Other NSAIDs and analgesics, including aspirin and acetaminophen, did not appear to have any effect on lowering a person’s risk of developing Parkinson’s. More research is needed as to how and why ibuprofen appears to reduce the risk of Parkinson’s disease, which affects up to one million people in the United States.”
The research will be presented at the American Academy of Neurology’s 62nd Annual Meeting in Toronto in April.
The study was supported by the National Institute of Neurological Disorders and Stroke.
CRN opens international headquarters
WASHINGTON The Council for Responsible Nutrition on Tuesday announced the opening of its international headquarters in Manno, Switzerland. CRN will be opening a new wholly-owned entity to be known as the Council for Responsible Nutrition-International (CRN-I), the dietary supplement industry association announced.
“This was a natural progression for CRN to formalize the work it’s been doing for decades by standing up for science-based principles for dietary/food supplements worldwide,” stated Mark LeDoux, CRN. “CRN-I will provide a new forum by which we can strengthen our current efforts, with a particular emphasis on promoting sound nutrition and food safety policies, and encouraging government bodies, regulators and other decision makers to make policy recommendations that are well-grounded in science. In this global economy, having a European-based platform from which to disseminate science-based policy recommendations has been imperative to maximize our influence on behalf of our multi-national members doing business around the world.”
The new organization announced its immediate first priority is to conduct a one-day scientific symposium –“Scientific Issues Related to Codex Goals” — taking place July 3 in Geneva, Switzerland, in tandem with the Codex Alimentarius Commission meeting. The CRN-I conference will include invited international regulators and policy makers, nutrition scientists and academics, to share perspectives on Codex-related issues relating to risk management and scientific standards for health claims.
“We have a responsibility to our members and to our consumers worldwide to ensure that regulators and policy makers have the opportunity to engage in intellectual, peer-reviewed, science-based discussions so that they can consider these viewpoints as part of their policy-making process,” LeDoux said.
The CRN-I Board will be announced at the first CRN-I annual meeting, scheduled for April 15 in Paris in conjunction with the meeting of the Codex Committee on General Principles.
For more information, visit www.crn-i.ch.
Shaking up protein times 6
ORLANDO, Fla. —BSN last month showcased its line of ready-to-drink protein supplements at the ECRM Vitamin, Diet & Sports Nutrition meeting here. The company’s RTD protein supplements already are best-sellers at specialty shop GNC and military retailer AAFES.
The new-to-mass RTD protein shake, called Syntha-6, features six proteins—including milk, whey and soy—that each are metabolized by the body at different rates, allowing for a more gradual supplementation of protein.
Sports enthusiasts and avid dieters may be credited with driving sales of protein supplements higher last year by some 22%; for the 52 weeks ended Dec. 26, 2009, sales of protein supplements reached $148.3 million across food, drug and mass (including Walmart), according to Nielsen Group data.
For 2010, BSN is planning $3.2 million in advertising.